Paroxetine

ADVERTISEMENT

Identification

Molecular formula
C19H24NO2
CAS Number
61869-08-7
IUPAC Name
9-methyl-3-[o-tolyl(phenyl)methoxy]-9-azabicyclo[3.3.1]nonane
Molecular Weight
329.41g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2770g/cm3
Synonyms
6605-93-2
Interesting facts

9-methyl-3-[o-tolyl(phenyl)methoxy]-9-azabicyclo[3.3.1]nonane: A Unique Compound

This intriguing compound, known as 9-methyl-3-[o-tolyl(phenyl)methoxy]-9-azabicyclo[3.3.1]nonane, belongs to a fascinating class of molecules characterized by complex bicyclic structures that have captivated the attention of chemists and pharmacologists alike.

Structural Attributes

  • Bicyclic Nature: The bicyclic structure contributes to unique steric and electronic properties, which may influence its biological activity.
  • Functional Groups: The presence of the methoxy and o-tolyl substituents suggests potential interactions in various chemical reactions, as well as relevance to medicinal chemistry.

Potential Applications

This compound could have potential applications in the pharmaceutical industry, particularly in the development of:

  • Analgesics: Its structural characteristics may help in designing compounds with pain-relieving properties.
  • Antidepressants: Compounds with similar bicyclic frameworks have been explored for their effectiveness in targeting mental health disorders.

Research Insights

The complex arrangement of atoms in this compound opens doors to myriad research possibilities. Chemists are particularly interested in:

  • Synthetic Pathways: Investigating effective methods for synthesizing this compound could lead to the discovery of new chemical reactions.
  • Interaction Studies: Understanding how this compound interacts with biological targets may enhance our knowledge of drug design.

As a compound that stands out due to its structure and potential implications, 9-methyl-3-[o-tolyl(phenyl)methoxy]-9-azabicyclo[3.3.1]nonane is a prime candidate for further study and exploration in the field of chemistry.

ADVERTISEMENT